Metabolomic identification of predictive and early biomarkers of cisplatin‐induced acute kidney injury in adult head and neck cancer patients
British Journal of Clinical Pharmacology · 2024
DOI: 10.1111/bcp.15666 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Yong Jin Lim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada. Hauptthemen laut MEDLINE: Cisplatin, Acute Kidney Injury, Metabolomics, Biomarkers. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Western University, Canadian Institutes of Health Research.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Aim
Cisplatin causes acute kidney injury (AKI) in approximately one third of patients. Serum creatinine and urinary output are poor markers of cisplatin‐induced AKI. Metabolomics was utilized to identify predictive or early diagnostic biomarkers of cisplatin‐induced AKI.
Methods
Thirty‐one adult head and neck cancer patients receiving cisplatin (dose ≥70 mg/m 2 ) were recruited for metabolomics analysis. Urine and serum samples were collected prior to cisplatin (pre), 24–48 h after cisplatin (24–48 h) and 5–14 days (post) after cisplatin. Based on serum creatinine concentrations measured at the post timepoint, 11/31 patients were classified with clinical AKI. Untargeted metabolomics was performed using liquid chromatography‐mass spectrometry (LC‐MS).
Results
Metabolic discrimination was observed between “AKI” patients and “no AKI” patients at all timepoints. Urinary glycine, hippuric acid sulfate, 3‐hydroxydecanedioc acid and suberate were significantly different between AKI patients and no AKI patients prior to cisplatin infusion. Urinary glycine and hippuric acid sulfate were lower (−2.22‐fold and −8.85‐fold), whereas 3‐hydroxydecanedioc acid and suberate were higher (3.62‐fold and 1.91‐fold) in AKI patients relative to no AKI patients. Several urine and serum metabolites were found to be altered 24–48 h following cisplatin infusion, particularly metabolites involved with mitochondrial energetics.
Conclusions
We propose glycine, hippuric acid sulfate, 3‐hydroxydecanedioc acid and suberate as predictive biomarkers of predisposition to cisplatin‐induced AKI. Metabolites indicative of mitochondrial dysfunction may serve as early markers of subclinical AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
- Division of Medical Oncology, Department of Oncology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
- Division of Nephrology, Department of Pediatrics, Hospital for Sick Children, Toronto, ON, Canada.
- Department of Paediatrics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
- Division of Clinical Pharmacology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
- Division of Nephrology, Department of Pediatrics, British Columbia Children's Hospital, Vancouver, BC, Canada.
ORCID-Profile: Michael J Rieder, Bradley L Urquhart
Förderung
- CIHR
- Western University
- Canadian Institutes of Health Research
Zitieren
APA
Lim, Y. J., Xiu, S. G., Kuruvilla, M. S., Winquist, E., Welch, S., Black, M., Faught, L. N., Lee, J., Rieder, M. J., Blydt-Hansen, T. D., Zappitelli, M., & Urquhart, B. L. (2024). Metabolomic identification of predictive and early biomarkers of cisplatin‐induced acute kidney injury in adult head and neck cancer patients. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15666
Vancouver
Lim YJ, Xiu SG, Kuruvilla MS, Winquist E, Welch S, Black M, et al. Metabolomic identification of predictive and early biomarkers of cisplatin‐induced acute kidney injury in adult head and neck cancer patients. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.15666
BibTeX
@article{Lim2024,
author = {Lim, Yong Jin and Xiu, Steven G and Kuruvilla, M Sara and Winquist, Eric and Welch, Stephen and Black, Morgan and Faught, Lauren N and Lee, Jasmine and Rieder, Michael J and Blydt-Hansen, Tom D and Zappitelli, Michael and Urquhart, Bradley L},
title = {Metabolomic identification of predictive and early biomarkers of cisplatin‐induced acute kidney injury in adult head and neck cancer patients},
journal = {British Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1111/bcp.15666}
}
EUVIMED